Enbrel (Etanercept), a fully human soluble TNFα receptor preparation, is a therapeutic for rheumatoid arthritis.
Daiichi Sankyo news release, August 18, 2014
Daiichi Sankyo starts phase III of Enbrel biosimilar in Japan
Window to Japan
Window to Japan
Enbrel (Etanercept), a fully human soluble TNFα receptor preparation, is a therapeutic for rheumatoid arthritis.
Daiichi Sankyo news release, August 18, 2014